Stocks · News reference

8-K filing — Arcadia Biosciences, Inc. (RKDA)

Sep 4, 2026, 8:05 PMSEC EDGAR

Filed: 2026-09-04 AccNo: 0001193125-26-383642 Size: 160 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01: Financial Statements and Exhibits

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

RKDA

Source: edgar
Observed: Sep 4, 2026, 8:05 PM
Checked: Sep 4, 2026, 8:05 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 13, 2026, 8:29 PMBenzinga Newsdesk
Arcadia Biosciences shares are trading higher after the company reported a year-over-year increase in its Q2 EPS results.
RKDA
BenzingaAug 13, 2026, 8:25 PMBenzinga Newsdesk
Arcadia Biosciences Q2 EPS $(2.09) Up From $(3.26) YoY, Sales $1.443M Down From $1.455M YoY
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(2.09) per share. This is a 35.89 percent increase over losses of $(3.26) per share from the same period last year. The company reported $1.443 million in
RKDA
BenzingaJun 26, 2026, 8:39 PMBenzinga Newsdesk
Arcadia Biosciences Files Prospectus Pursuant To Which Selling Stockholders May Offer Up To 11.92M Shares Of Common Stock For Resale
RKDA

8-K filing — Arcadia Biosciences, Inc. (RKDA)

Connected Markets

Related Headlines

Arcadia Biosciences shares are trading higher after the company reported a year-over-year increase in its Q2 EPS results.

Arcadia Biosciences Q2 EPS $(2.09) Up From $(3.26) YoY, Sales $1.443M Down From $1.455M YoY

Arcadia Biosciences Files Prospectus Pursuant To Which Selling Stockholders May Offer Up To 11.92M Shares Of Common Stock For Resale